Clinical Trials Logo

Clinical Trial Summary

PtenTurkiye.org' is a national ( Turkish), web-based registry for PTEN Hamartoma Tumour ( PHTS) syndrome established in 2022. It is designed to increase awareness, gather scientific knowledge by collaboration and increase data accessibility, collect high-quality data on the epidemiology, genetic background and natural history of PHTS especially for pediatric patients so that more accurate follow up guidelines can be recommended.


Clinical Trial Description

There is a limited understanding of the natural history of childhood-onset PTEN Hamartoma Tumour Syndrome (PHTS) as a cancer predisposition syndrome. Patient registries are important for longitudinal follow up of these patients. Our aim is to create a Turkish registry especially for pediatric PHTS patients, but registry is open to adult PHTS patients as well. The purpose is to engage families with children with PHTS in the data-sharing process to accelerate research and drug development and share their experiences with other families as a support if they agree to do so. The registry is open to both adults and children with PHTS. Most pediatric patients with PHTS have autism spectrum disorders, developmental delays and/or intellectual deficiencies. Patient registry will help us see if they are getting appropriate behaviour interventions. There is no consensus on the guidelines for cancer surveillance in children. We will follow these patients according to 'pediatric follow-up protocol for PTEN mutated children' created by Ciaccio et al. Patient registry will also help if these guidelines are sufficient or need improvements. Once the individual or their parent/guardian has consented to participate in the registry, the researchers will collect their past and current medical, familial, and other necessary demographic information from their medical records and face to face interviews. We will follow up patients every 6 months or earlier if needed. We will do thorough physical and dysmorphological exam (using autism research exchange dysmorphology check list). For patients with autism and other behavioral problems we will refer them to child and adolescent psychiatry clinics for evaluation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06462430
Study type Observational [Patient Registry]
Source Acibadem University
Contact Hande Kaymakcalan Celebiler, MD
Phone +902165004444
Email hande.celebiler@acibadem.edu.tr
Status Recruiting
Phase
Start date November 1, 2022
Completion date January 2, 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05671107 - Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
Active, not recruiting NCT04094675 - Sirolimus for Cowden Syndrome With Colon Polyposis Phase 2
Not yet recruiting NCT03630523 - Response of Immune System to Flu Vaccination in PHTS N/A
Recruiting NCT02461446 - Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Completed NCT02991807 - RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome Phase 1/Phase 2
Not yet recruiting NCT06080165 - Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations Phase 1/Phase 2
Recruiting NCT03050268 - Familial Investigations of Childhood Cancer Predisposition